Cargando…

Enzyme activated alkylating agents.

Detalles Bibliográficos
Autores principales:	Ball, C. R., Double, J. A., Goodban, J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1973
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009087/ https://www.ncbi.nlm.nih.gov/pubmed/4353389

Ejemplares similares

Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
por: Tran, Thai Q., et al.
Publicado: (2017)

Proceedings: A comparison of chemical and microbiological methods for estimating alkylating agent concentration.
por: Toogood, S. M., et al.
Publicado: (1974)

Urinary markers for exposures to alkylating or nitrosating agents.
por: Wishnok, J S, et al.
Publicado: (1993)

Immobilization of Lipases on Alkyl Silane Modified Magnetic Nanoparticles: Effect of Alkyl Chain Length on Enzyme Activity
por: Wang, Jiqian, et al.
Publicado: (2012)

Improving the therapeutic index of two alkylating agents.
por: Millar, J. L., et al.
Publicado: (1980)

Proceedings: Alkylating agents as industrial carcinogens.
por: Munn, A.
Publicado: (1975)

Ablation of murine jejunal crypts by alkylating agents.
por: Moore, J. V.
Publicado: (1979)

Polyphenols enhance the activity of alkylating agents in leukaemia cell lines
por: Mahbub, Amani A., et al.
Publicado: (2019)

Selectivity and potency; are we doing the right things to find anti-cancer agents with these properties?
por: Double, J. A.
Publicado: (1992)

Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents
por: Zamperini, C., et al.
Publicado: (2017)

Proceedings: Influence of transplantation site on the establishment of human tumour xenografts in immunosuppressed mice.
por: Double, J. A., et al.
Publicado: (1975)

Proceedings: Transplantable adenocarcinomata of the colon in mice as possible models for chemotherapy.
por: Ball, C. R., et al.
Publicado: (1975)

Alcohols as alkylating agents in heteroarene C–H functionalization
por: Jin, Jian, et al.
Publicado: (2015)

Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma
por: Conroy, Michael, et al.
Publicado: (2017)

Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent
por: Ball, Daniel P., et al.
Publicado: (2016)

Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.
por: Babbage, J. W., et al.
Publicado: (1982)

Nearest neighbor affects G:C to A:T transitions induced by alkylating agents.
por: Glickman, B W, et al.
Publicado: (1987)

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
por: Egea, Javier, et al.
Publicado: (2022)

Engineered Enzymes Enable Selective N‐Alkylation of Pyrazoles With Simple Haloalkanes
por: Bengel, Ludwig L., et al.
Publicado: (2021)

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.
por: Damia, G., et al.
Publicado: (1996)

Proceedings: The role of alkaline phosphatase in the release of p-hydroxy aniline mustard from its phosphate conjugate.
por: Workman, P., et al.
Publicado: (1975)

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
por: Bibby, M. C., et al.
Publicado: (1987)

Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
por: Paiva, C, et al.
Publicado: (2015)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

Alkylating anticancer agents and their relations to microRNAs
por: Biersack, Bernhard
Publicado: (2019)

Potential alkylating agents from the oxidation of carcinogenic cyclic n-nitrosamines.
por: Challis, B. C., et al.
Publicado: (1973)

The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.
por: Bibby, M. C., et al.
Publicado: (1988)

Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
por: McNally, N. J., et al.
Publicado: (1983)

Dose-dependent spatiotemporal responses of mammalian cells to an alkylating agent
por: Rancourt, Ann, et al.
Publicado: (2019)

Self-Assembled Alkylated Polyamine Analogs as Supramolecular Anticancer Agents
por: Sil, Diptesh, et al.
Publicado: (2022)

Alcohols as Alkylating Agents in the Cation‐Induced Formation of Nitrogen Heterocycles
por: Cox, Lydia, et al.
Publicado: (2022)

PM00104 (Zalypsis(®)): A Marine Derived Alkylating Agent
por: Petek, Bradley J., et al.
Publicado: (2014)

DNA Damage Induced by Alkylating Agents and Repair Pathways
por: Kondo, Natsuko, et al.
Publicado: (2010)

The Sensitivity to Chemotherapeutic Agents of a Rat Tumour Grown in Immunosuppressed Mice
por: Sheard, Christine E., et al.
Publicado: (1971)

Alkylboronic acids as alkylating agents: photoredox-catalyzed alkylation reactions assisted by K(3)PO(4)
por: Yue, Fuyang, et al.
Publicado: (2022)

BrtB is an O-alkylating enzyme that generates fatty acid-bartoloside esters
por: Reis, João P. A., et al.
Publicado: (2020)

DNA direct reversal repair and alkylating agent drug resistance
por: Gutierrez, Roberto, et al.
Publicado: (2021)

Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
por: Hussein, D, et al.
Publicado: (2009)

Alkyl Gallates as Potential Antibiofilm Agents: A Review
por: Rayan, Mahmoud, et al.
Publicado: (2023)

Resistance to alkylating agents and tumour differentiation in xenografts of small cell lung cancer.
por: Berman, R., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_e2dbd9k3l11s84llummq2rfe01